Top Antivir Med. 2017 Dec/Jan;24(4):132-133.

2017 Update of the Drug Resistance Mutations in HIV-1.

Wensing AM¹, Calvez V², Günthard HF³, Johnson VA⁴, Paredes R⁵, Pillay D⁶, Shafer RW⁷, Richman DD⁸.

Author information

1: University Medical Center Utrecht, The Netherlands.
2: Pierre et Marie Curie University and Pitié-Salpêtrière Hospital, Paris, France.
3: University Hospital Zurich, University of Zurich, Switzerland.
4: Birmingham Veterans Affairs Medical Center and the University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA.
5: HIV Unit and IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
6: Africa Health Research Institute, KwaZulu Natal, South Africa, and University College London, United Kingdom.
7: Stanford University Medical School, Stanford, CA, USA.
8: Veterans Affairs San Diego Healthcare System and University of California San Diego, San Diego, CA, USA.

Abstract

The 2017 edition of the IAS-USA drug resistance mutations list updates the figures last published in November 2015. The mutations listed are those that have been identified by specific criteria for evidence and drugs described. The figures are designed to assist practitioners in identifying key mutations associated with resistance to antiretroviral drugs and, therefore, in making clinical decisions regarding antiretroviral therapy.